Taken together, these findings provide a framework to understand the role of ACLY in regulating the proinflammatory activation and gluco-lipogenesis in ECs, highlighting the potential of ACLY as a novel therapeutic target for treating sepsis-associated EC dysfunction and organ injuries. This evidence concerns the gene ACLY and Sepsis.